HOOKIPA Pharma Inc.

NasdaqCM:HOOK 주식 보고서

시가총액: US$63.1m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

HOOKIPA Pharma 관리

관리 기준 확인 3/4

HOOKIPA Pharma's CEO는 Joern Aldag, Jun2016 에 임명되었습니다 의 임기는 6.5 년입니다. 총 연간 보상은 $ 1.13M, 50.2% 로 구성됩니다. 50.2% 급여 및 49.8% 보너스(회사 주식 및 옵션 포함). 는 $ 50.82K 가치에 해당하는 회사 주식의 0.073% 직접 소유합니다. 50.82K. 경영진과 이사회의 평균 재임 기간은 각각 7.6 년과 5.2 년입니다.

주요 정보

Joern Aldag

최고 경영자

US$1.1m

총 보상

CEO 급여 비율50.2%
CEO 임기8yrs
CEO 소유권0.07%
경영진 평균 재임 기간7.6yrs
이사회 평균 재임 기간5.2yrs

최근 관리 업데이트

Recent updates

Why Investors Shouldn't Be Surprised By HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 34% Share Price Plunge

Jun 22
Why Investors Shouldn't Be Surprised By HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 34% Share Price Plunge

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Shares Fly 25% But Investors Aren't Buying For Growth

Apr 28
HOOKIPA Pharma Inc. (NASDAQ:HOOK) Shares Fly 25% But Investors Aren't Buying For Growth

Analysts Just Made A Major Revision To Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenue Forecasts

Mar 24
Analysts Just Made A Major Revision To Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenue Forecasts

Need To Know: The Consensus Just Cut Its HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates For 2023

Aug 11
Need To Know: The Consensus Just Cut Its HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates For 2023

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Just Slashed This Year's Revenue Estimates By 17%

May 16
HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Just Slashed This Year's Revenue Estimates By 17%

Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?

Apr 26
Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?

Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

Nov 19
Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

HOOKIPA wins FDA nod to start clinical studies for prostate cancer therapy

Jul 25

Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts

May 18
Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts

Hookipa: Speculative Biotech With Key Catalysts In 2022

Mar 29

Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?

Oct 01
Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?

Checking Back In On HOOKIPA Pharma

Jun 22

Hookipa Pharma's HB-200 shows "positive" clinical efficacy in HPV16+ cancers

Jun 08

Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?

Apr 19
Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?

CEO 보상 분석

Joern Aldag 의 보수는 HOOKIPA Pharma 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$48m

Dec 31 2023US$1mUS$567k

-US$82m

Sep 30 2023n/an/a

-US$69m

Jun 30 2023n/an/a

-US$68m

Mar 31 2023n/an/a

-US$67m

Dec 31 2022US$1mUS$390k

-US$65m

Sep 30 2022n/an/a

-US$74m

Jun 30 2022n/an/a

-US$76m

Mar 31 2022n/an/a

-US$76m

Dec 31 2021US$3mUS$572k

-US$76m

Sep 30 2021n/an/a

-US$67m

Jun 30 2021n/an/a

-US$60m

Mar 31 2021n/an/a

-US$50m

Dec 31 2020US$2mUS$495k

-US$44m

Sep 30 2020n/an/a

-US$42m

Jun 30 2020n/an/a

-US$40m

Mar 31 2020n/an/a

-US$45m

Dec 31 2019US$6mUS$469k

-US$43m

Sep 30 2019n/an/a

-US$35m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$21m

Dec 31 2018US$548kUS$362k

-US$16m

Dec 31 2017US$542kUS$339k

-US$13m

보상 대 시장: Joern 의 총 보상 ($USD 1.13M )은 US 시장( $USD 683.56K ).

보상과 수익: Joern 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Joern Aldag (65 yo)

8yrs

테뉴어

US$1,130,427

보상

Mr. Joern Aldag has been Chief Executive Officer at Hookipa Biotech GmbH since June 16, 2016. He has been a Director of Hookipa Pharma Inc. since December 2017 and is its Chief Executive Officer since June...

리더십 팀

이름위치테뉴어보상소유권
Joern Aldag
CEO & Director8yrsUS$1.13m0.073%
$ 45.9k
Reinhard Kandera
CFO & Director7.2yrsUS$725.48k0.044%
$ 27.5k
Rolf Zinkernagel
Co-Founder13.4yrs데이터 없음데이터 없음
Andreas Bergthaler
Co-Founder13.4yrs데이터 없음데이터 없음
Lukas Flatz
Co-Founder13.4yrs데이터 없음데이터 없음
Roman Necina
Chief Operations Officerless than a year데이터 없음데이터 없음
Klaus Orlinger
Chief Scientific Officer2.3yrs데이터 없음데이터 없음
Matthew L. Beck
Executive Director of Investor Relationsno data데이터 없음데이터 없음
Michael Szumera
Executive Director of Communicationsno data데이터 없음데이터 없음
Mark Winderlich
Chief Development Officerless than a year데이터 없음데이터 없음
Daniel Courtney
Corporate Secretaryno data데이터 없음데이터 없음

7.6yrs

평균 재임 기간

55.5yo

평균 연령

경험이 풍부한 관리: HOOK 의 관리팀은 노련하고 경험 (평균 재직 기간 7.6 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Joern Aldag
CEO & Director6.5yrsUS$1.13m0.073%
$ 45.9k
Reinhard Kandera
CFO & Director6yrsUS$725.48k0.044%
$ 27.5k
Jan G.J. de Winkel
Independent Chairman of the Board7.4yrsUS$127.98k0.0092%
$ 5.8k
Sander Van Deventer
Scientific Advisory Member4yrsUS$23.76k데이터 없음
Malte Peters
Director1.4yrsUS$232.31k0%
$ 0
Mary Coelho
Independent Director1.2yrsUS$85.88k0%
$ 0
Julie O'Neill
Independent Non-Executive Director5.6yrsUS$67.74k0.0050%
$ 3.2k
David Kaufman
Independent Director5.2yrsUS$71.74k0.0046%
$ 2.9k
Timothy Reilly
Independent Non-Executive Director2.2yrsUS$71.74k0%
$ 0

5.2yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: HOOK 의 이사회는 경험(평균 재직 기간 5.2 년)으로 간주됩니다.